Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001348362-25-000006
Filing Date
2025-05-16
Accepted
2025-05-16 16:44:04
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4252
  Complete submission text file 0001348362-25-000006.txt   5828
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 704 ALEXANDER STREET VANCOUVER A1 V6A 1E3
Business Address
Bhullar Baljinder (Reporting) CIK: 0001401225 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 25960017